Bahcc1 对 MLL-ENL 介导白血病小鼠模型中的异常表观遗传程序至关重要
该研究在小鼠模型中探讨造血干/祖细胞(HSPC)对 MLL-ENL 介导转化的易感性差异,鉴定出 Bahcc1 为候选基因。MLL-ENL 通过结合 Bahcc1 启动子上调其表达,Bahcc1 至少部分通过抑制 H3K27me3 标记的 Cdkn1c 参与永生化。小鼠骨髓移植实验显示敲低 Bahcc1 可抑制 MLL-ENL 的白血病生成活性。
要点
- 长期重建造血干细胞亚群对 MLL-ENL 介导的转化最易感。
- MLL-ENL 结合 Bahcc1 启动子上调其表达,Bahcc1 参与永生化。
- 小鼠骨髓移植中敲低 Bahcc1 抑制 MLL-ENL 白血病生成活性。
核心结论
- 研究揭示 HSPC 具有不同的永生化潜能,并提出 MLL 融合-Bahcc1 轴,可能为 MLL 融合介导白血病的分子靶向治疗提供线索。
研究设计与样本
- 采用小鼠模型研究 MLL-ENL 介导的白血病转化,基于 CD150/CD48 定义分析 HSPC 各分化阶段。
- 通过分子机制分析鉴定 Bahcc1 为参与白血病转化易感性差异的候选基因。
- 利用小鼠骨髓移植实验分析 Bahcc1 敲低对 MLL-ENL 白血病生成活性的影响。
主要发现
- 基于 CD150/CD48 定义的分析显示,长期重建造血干细胞亚群对 MLL-ENL 介导的转化最易感。
- MLL-ENL 通过结合 Bahcc1 启动子上调 Bahcc1 表达。
- Bahcc1 至少部分通过抑制 H3K27me3 标记的 Cdkn1c 参与 MLL-ENL 介导的永生化。
- 小鼠骨髓移植分析显示,敲低 Bahcc1 抑制 MLL-ENL 的白血病生成活性。
- 公共数据库中,BAHCC1 高表达与儿童 AML 不良预后相关,且 MLL-AF9-AML 中 BAHCC1 表达显著低于其他 MLL 融合 AML。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In leukemogenesis, genotoxic stress in hematopoietic stem and progenitor cells (HSPCs) drives individual context-dependent programs of malignant transformation. In light of the various differentiation stages of HSPCs based on a recently revised definition using CD150/CD48, our analyses showed that a subpopulation of long-term repopulating HSCs was most susceptible to MLL-ENL-mediated transformation. An analysis of the molecular mechanism identified Bromo-adjacent homology domain and coiled-coil containing 1 (Bahcc1), which encodes a reader molecule of trimethylated histone H3 lysine 27 (H3K27me3), as a candidate gene involved in distinct susceptibility to leukemic transformation. Interestingly, Bahcc1 was previously reported to be highly expressed in acute myeloid leukemia (AML) with an unfavorable prognosis, including some cases of MLL-rearranged AML. We found that MLL-ENL upregulated Bahcc1 through binding to its promoter, and that Bahcc1 was involved in MLL-ENL-mediated immortalization at least partly through repression of H3K27me3-marked Cdkn1c. Analyses using bone marrow transplantation in mice showed that depletion of Bahcc1 suppressed the leukemogenic activity of MLL-ENL. In a public database, high BAHCC1 expression was found to be associated with a poor prognosis in pediatric AML, in which BAHCC1 expression was significantly lower in MLL-AF9-AML than in other MLL-fusion-AML. These findings shed light on the distinct immortalization potential of HSPCs and suggest a novel MLL-fusion-Bahcc1 axis, which may lead to development of molecular targeted therapy against MLL-fusion-mediated leukemia.
引用
- Nakamura A, Masuya M, Shinmei M, et al. Bahcc1 is critical for the aberrant epigenetic program in a mouse model of MLL-ENL-mediated leukemia. Blood Adv. 2024. PMID: 38452334. doi:10.1182/bloodadvances.2023011320
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。